Dr. Mikhail V. Blagosklonny’s Lifetime Study for Mankind – The Anti-Anging Drug

Ageing or aging is the process of becoming older until our bodies can no longer function properly and will stop working at some point.The most accepted theory, to this date, is that aging is the accumulation of damage that happens to the body of living things as time progresses, and their lives keep going until there is enough damage that they can no longer resist.This “accumulation of damage” is what causes cells, organisms and whole systems of the body to fail, while there also exist internal causes of damage that help deteriorate the tissues of the body over time.However, an extensive study of the doctor Mikhail V. Blagosklonny has shown that this is not actually the case, but something completely different might be the cause of cancer as we know of it today.

According to his studies, aging is not an accumulation of damage, but it is a continuation of the process of growth that is experienced in the youth of men and women.As life progresses, the bodies of living beings grow as much as their DNA dictates, and their alimentation provides, but the DNA also dictates when the growth stops happening and the systems of the body start moving towards a period of life where deterioration happens naturally. One can live their lives eating healthily and not having external damage at all, but their body will still age because it is the natural course of what happens to all living beings.With these discoveries, however, Dr. Mikhail V. Blagosklonny has furthered his research into developing the next-gen anti-aging drug. As much as it sounds fantastic and utopic, the expert is actually reaching positive results to what might be the first remedy that actually slows down aging and prevents diseases that come with the process.

According to the specialist, the hyperfunction theory, as he likes to call it, allows scientists to now understand where the aging code comes from, and it can be traced back to signaling pathways such as what they call “TOR,” which stands for “Target of Rapamycin,” the name of the drug that is the scientist Blagosklonny developed Oncotarget .While it is an anti-aging drug of sorts, people might think that this is will make humans have some sort of immortal beings. Dr. Mikhail V. Blagosklonny addresses this issue when he explains that the drug he is developing simply slows down aging to abolish diseases like cancer that happen to old people more than younger ones. These diseases will not be the causes of death anymore, at least not of the same magnitude that it has been for years, but there will always exist additional events that cause the death of individuals.The TOR-Centric Model, which comprise the pathway that is essential for the growth and development of human beings, can be found in three different sources currently. The first one being the person’s genetics; the second being the cellular senescence (when the cycle of our body cells is blocked) because the rapamycin suppresses geroconversion. The third and last source of the TOR-Centric model are diseases like Parkinson and Alzheimer, for the surprise of most scientists.Today, Dr. Mikhail V. Blagosklonny is still furthering his researches to find out more about aging and the diseases that come with it.

Leave a Reply

Your email address will not be published. Required fields are marked *